Clinical Trial Update: Early Pharmacological and Immune Monitoring After Conversion to Belatacept in Renal Transplant Patients

View source ↗

Summary

This clinical trial update reports early pharmacological and immune monitoring data after converting kidney transplant recipients to belatacept.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Nulojix (belatacept)

Snippet

Sponsor: University Hospital, Tours | Conditions: Renal Transplant, Conversion | Status: COMPLETED